Stocks
BMO Boosts Merck Price Target to $170
Merck & Co., Inc.'s (NYSE:MRK) price target was raised to $170.00 by BMO Capital Markets, indicating a potential upside of 12.49% from its current price.
The firm currently has an 'outperform' rating on the stock and several other equities research analysts have recently commented on MRK. Morgan Stanley raised shares of Merck & Co., Inc. from an 'equal weight' rating to an 'overweight' rating and lifted their price target for the stock from $116.00 to $179.00.
UBS Group upped its price objective on shares of Merck & Co., Inc. from $145.00 to $175.00, giving the company a 'buy' rating in a research report on Thursday.